WHC is still in active development. Read this to understand our approach.
depiction of CNBGNNVCVSKAQZ-UHFFFAOYSA-N.svg
tripsit

benzydamine

Verificar en tripsit

psychonaut

Benzydamine

Verificar en psychonaut

isomerdesign

Benzydamine

Verificar en isomerdesign

druglab

Benzydamine

Verificar en druglab

drugmap

Benzydamine

Verificar en drugmap

wiki

Benzydamine

Verificar en wiki

Data

InChI: InChI=1S/C19H23N3O/c1-21(2)13-8-14-23-19-17-11-6-7-12-18(17)22(20-19)15-16-9-4-3-5-10-16/h3-7,9-12H,8,13-15H2,1-2H3

Sinónimos: SR-01000799149-2,BSPBio_000234,NCGC00016397-07,HMS2090P22,Q793143,1-Propanamine, N,N-dimethyl-3-[[1-(phenylmethyl)-1H-indazol-3-yl]oxy]-,3-(1-benzyl-1H-indazol-3-yloxy)-N,N-dimethylpropan-1-amine,3-[(1-benzyl-1H-indazol-3-yl)oxy]-N,N-dimethylpropan-1-aminie, Benzidamina,AKOS005530662,Prestwick3_000297,NCGC00016397-01,5-23-11-00248 (Beilstein Handbook Reference),Prestwick0_000297,SB16913, Benzydaminum, Benzydaminum [INN-Latin],ZINC2020083, Benzydamine (INN),AC-15604,ALBB-027259, 1-Benzyl-3-(3-(dimethylamino)propoxy)-1H-indazole,Benzydamine,1H-Indazole, 1-benzyl-3-(3-(dimethylamino)propoxy)-,1benzyl-3-[3-(dimethylamino)propoxy]-1H-indazole,SCHEMBL26172, Benzindamine, Apo-Benzydamine,2-{[(2-Methoxyethyl)amino]-carbonyl}cyclohexanecarboxylicacid,Benzydaminum [INN-Latin],Benzindamine,1-Benzyl-3-[3-(dimethylamino)propoxy]-1H-indazole,EN300-12576563,Benzidamina,C 1523,CHEMBL12610,BENZYDAMINE, Apo-Benzydamine (TN),Benzydamine (INN),BRD-K28542495-003-03-6,1-BENZYL-1H-INDAZOL-3-YL 3-(DIMETHYLAMINO)PROPYL ETHER, Benzidamina [DCIT],BRN 0896536,STK711092,Prestwick1_000297, Bencidamina [INN-Spanish],{3-[(1-benzyl-1H-indazol-3-yl)oxy]propyl}dimethylamine, {3-[(1-benzyl-1H-indazol-3-yl)oxy]propyl}dimethylamine, Benzydamine [INN:BAN],BENZYDAMINE [WHO-DD],benzydamide,NCGC00016397-02,UNII-4O21U048EF,CHEBI:94563,Apo-Benzydamine (TN), C 1523,DTXSID7047859,Bencidamina [INN-Spanish],Benzidamina [DCIT],1-Propanamine, N,N-dimethyl-3-((1-(phenylmethyl)-1H-indazol-3-yl)oxy)-,Prestwick2_000297,3-(1-benzylindazol-3-yl)oxy-N,N-dimethylpropan-1-amine,Bencidamina,SPBio_002453, 3-[(1-benzyl-1H-indazol-3-yl)oxy]-N,N-dimethylpropan-1-amine,Benzydaminum,BBL009932,642B728,N,N-DIMETHYL-3-((1-(PHENYLMETHYL)-1H-INDAZOL-3-YL)OXY)-1-PROPANAMINE, Benzidamine,BDBM50103598,1-Benzyl-3-(3-(dimethylamino)propoxy)-1H-indazole,4O21U048EF,Benzydamine [INN:BAN],BPBio1_000258,SR-01000799149,FT-0740906, 3-(1-benzylindazol-3-yl)oxy-N,N-dimethylpropan-1-amine,SBI-0206866.P001,3-[(1-benzyl-1H-indazol-3-yl)oxy]-N,N-dimethylpropan-1-amine,DB09084,Apo-Benzydamine,3-(1-Benzylindazol-3-yl)oxy-N,N-dimethylpropan-1-amine,642-72-8,BRD-K28542495-003-07-7,D07516,tantum,BENZYDAMINE [MI], Benzydamine Monohydrochoride,CAS-132-69-4,EINECS 211-388-8,N-(3-[(1-Benzyl-1H-indazol-3-yl)oxy]propyl)-N,N-dimethylamine #,N,N-dimethyl-3-[[1-(phenylmethyl)-3-indazolyl]oxy]-1-propanamine,BENZYDAMINE [INN],BRD-K28542495-001-01-4,Benzidamine

Estimated data

Solubilidad: -3.517 (log(S) in mol/L prediction using SolTranNet)

Blood Brain Barrier Permeability: Yes (prediction using frontiersin.org)

Addictivity Prediction: 68.1% (prediction based on www.mdpi.com)

Similitudes

The following is a set of comparisons to understand the properties of this compound. This is still higly experimental and is still under active development. Please refer to our series of blog posts to fully understand our approach and its limitations. This information is for informational purposes only and should not be construed as medical advice.